Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYıldız, Birsen Pınar
dc.contributor.authorHattatoğlu, Didem Görgün
dc.contributor.authorAydın, Cihan
dc.contributor.authorDarçın, Gülnihal
dc.date.accessioned2025-05-21T06:51:35Z
dc.date.available2025-05-21T06:51:35Z
dc.date.issued2023en_US
dc.identifier.citationYıldız, B. P., Hattatoğlu, D. G., Aydin, C., & Darçın, G. (2023). Fatigue has a prominent impact on health lasting 12-weeks after COVID-19 infection. Malawi Medical Journal, 35(2), 124-129.en_US
dc.identifier.issn19957262
dc.identifier.urihttps://10.4314/mmj.v35i2.9
dc.identifier.urihttps://hdl.handle.net/20.500.12513/7354
dc.description.abstractBackground While the amount of information on many issues related to COVID-19 has increased, the long-term consequences of illness and disability remain largely unclear. In previous studies on COVID-19 infections, long-lasting functional and symptomatic abnormalities have also been shown. It is predicted that survivors of COVID-19 may have to deal with physical or psychological problems later. Aim We aimed to evaluate long-lasting symptoms including fatigue and investigate the associated risk factors. Methods In this prospective cohort study, 132 consecutive COVID-19 patients who were previously diagnosed and admitted 13±1 weeks after diagnosis were included. The Functional Assessment of Chronic Illness Therapy (FACIT) – Fatigue Scale, the Beck Anxiety Inventory, the Beck Depression Inventory, and the Lawton Instrumental Activities of Daily Living (IADL) Scale were applied in the follow-up visit. Results The median age of the patients (76 male, 56 female) was 52. Eighty (61%) of the patients were hospitalized, while 52 (39%) of them were not hospitalized. At least one symptom persisted in 103 (78%) patients, with fatigue (n=48, 36%) being the most common symptom. Both dyspnea and fatigue were more prominent in women than in men (34% vs. 11%, p=0.001 and 46% vs 29%, p=0.03; respectively). Persisted symptoms including fatigue were not significantly associated with hospitalization status. The FACIT scores of the patients at 12 weeks were positively associated with their depression and anxiety levels (R: 0.55, p=0.0001 and R: 0.42, p=0.0001), while they were negatively associated with their IADL scores (R:-0.25, p=0.004). Conclusions Fatigue was the most frequent persistent symptom. The initial fatigue scores were higher in the severely ill patients. Persistent fatigue was not associated with disease severity but was closely associated with anxiety and depression. © 2023 Kamuzu University of Health Sciences.en_US
dc.language.isoengen_US
dc.publisherMalawi Medical Journalen_US
dc.relation.isversionof10.4314/mmj.v35i2.9en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectFatigueen_US
dc.subjectPandemicen_US
dc.subjectPersistent Symptomsen_US
dc.subjectRisk Factorsen_US
dc.titleFatigue has A Prominent İmpact on Health Lasting 12-Weeks after COVID-19 İnfectionen_US
dc.typearticleen_US
dc.relation.journalMalawi Medical Journalen_US
dc.contributor.departmentTıp Fakültesien_US
dc.identifier.volume35en_US
dc.identifier.issue2en_US
dc.identifier.startpage124en_US
dc.identifier.endpage129en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster